(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

UROVANT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

UROVANT

ST13

US500000079238436

Class

42, 44

Filing

79238436

Registration

5876239

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

62

Latest update

05/19/2026

Trademark type

Word

Nice classes

42, 44

Filing date

06/05/2018

Registration date

10/08/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/24/2026

Last transaction

05/19/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

CH

Examiner

GILLES, DEBORAH LYNN MEINERS

Law office

M10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Urovant Sciences GmbH

Representatives

Jeffrey R. Cadwell Dorsey & Whitney LLP

Technical classification

Nice Classes

Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Scientific and technological services as well as research and design services relating theretotechnical research in the fields of pharmaceuticalsmedical devices and biological studies; biomedical and pharmaceutical research services; research in the field of therapeutic biological and pharmaceutical preparations; pharmaceutical research and development; provision of information relating to scientific research in the field of pharmaceutical products and biomedicine

Class 44

Provision of health information and medical information; provision of information concerning the diagnosticprophylactic and therapeutic properties of pharmaceutical and biological preparations for prevention and treatment of diseasesdisorders and pathologies

Publications

History of USPTO decisions and trademark events.

62 publications found

C71T

CANCELLED SECTION 71

04/24/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/13/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

10/08/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/03/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

10/03/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/03/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/03/2024

WOAG

WITHDRAWAL OF ATTORNEY GRANTED

04/12/2024

WOAR

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

04/12/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/08/2024

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

04/08/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/08/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/08/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/08/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/08/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/23/2024

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

03/18/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/25/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/29/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/28/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/28/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

03/28/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/28/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/28/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/28/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/21/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/03/2020

FIMP

FINAL DISPOSITION PROCESSED

02/03/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/08/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

10/08/2019

GPNX

NOTIFICATION PROCESSED BY IB

08/02/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/23/2019

PUBO

PUBLISHED FOR OPPOSITION

07/23/2019

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

07/17/2019

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

07/17/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/03/2019

ALIE

ASSIGNED TO LIE

06/14/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/03/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/31/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/30/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/29/2019

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

05/29/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/12/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/12/2019

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

04/09/2019

GNFR

FINAL REFUSAL E-MAILED

04/09/2019

CNFR

FINAL REFUSAL WRITTEN

04/09/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/23/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/22/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/22/2019

RFNT

REFUSAL PROCESSED BY IB

10/13/2018

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/11/2018

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/25/2018

RFRR

REFUSAL PROCESSED BY MPU

09/24/2018

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/23/2018

CNRT

NON-FINAL ACTION WRITTEN

09/22/2018

DOCK

ASSIGNED TO EXAMINER

09/22/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/29/2018

MAFR

APPLICATION FILING RECEIPT MAILED

08/18/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/14/2018

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

08/13/2018

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/09/2018

Continuous trademark protection

Get notified about every new filing that threatens UROVANT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.